- Home
- About
- Section Advisors
- Meet Our Field Medical Affairs Team
- Speakers Bureau
- Supporting Organizations
- Contact Us
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Infographics
- Learning Tracks
- Podcasts
- Shareable/Downloadable Content
- Videos
- PsychUSim
- PsychU Roleplay
- Frameworks In Health & Quality Resources
- Mental Health System Guidebooks
- Psychiatric Scales
- Psychopharmacology
- Supporting Organizations
The Depression Dance: Navigating Unresolved Symptoms & Other Treatment Complexities
Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
The Depression Dance: Navigating Unresolved Symptoms & Other Treatment Complexities
Residual symptoms of depression are very common in patients who are classified as being in response or even remission. In individuals with residual symptoms, we see an increased risk of functional & interpersonal impairments, as well as a significantly increased risk for recurrence of depression. For many patients, residual symptoms can persist for months after an episode of Major Depressive Disorder (MDD) and can be complicated by a host of co-occurring medical conditions, leaving health care providers and patients frustrated and searching for effective treatment strategies.
Please join PsychU for a brainstorming panel discussion featuring pre-eminent leaders in mental health. Listen in as moderator, John Awad, MD – Senior Clinical and Science Liaison at Otsuka Pharmaceuticals, discusses MDD unresolved symptoms with an expert panel. They will identify treatment goals in MDD patients with a focus on partial response and unresolved/residual symptoms, review most common residual symptoms in MDD, and highlight some complexities associated with residual symptoms in depression.
Featuring
Gaurava Agarwal, MD
Chief wellness executive, Northwestern Medicine Director of Faculty Wellness, Northwestern University
MoreGaurava Agarwal, MD serves as the Major Depressive Disorder Section Advisor for PsychU. In addition, he is the Chief Wellness Executive, Northwestern Medicine Medical Groups; Associate Professor for the Department of Psychiatry and Behavioral Science and Medical Education, and Director of Medical Student Education in Psychiatry at Northwestern University’s Feinberg School of Medicine. He also is the Director of Physician Well-Being for Northwestern Medicine’s Medical Groups.Christine Yu Moutier, MD
Esteemed psychiatrist, Chief Medical Officer of The American Foundation for Suicide Prevention, and PsychU MDD Section Advisor.
MoreChristine Yu Moutier is a leader in the field of suicide prevention who joined AFSP in 2013. It is through her passion and commitment to the work that we see a lasting impact via research, education and support to communities across the U.S. She has testified before the U.S. Congress and provided multiple Congressional briefings on suicide prevention, presented to the White House, spoken at the National Academy of Sciences, she co-anchored CNN’s Finding Hope suicide prevention town hall, and has appeared as an expert in The New York Times, The Washington Post, Time magazine, The Economist, The Atlantic, Anderson Cooper 360, the BBC, CNN, NBC and other print and television outlets. Throughout her career she has focused on training healthcare leaders, physicians, and patient groups in order to change the healthcare system’s approach to mental health, fighting stigma and optimizing care for those suffering from mental health conditions. In addition to co-founding AFSP’s San Diego Chapter, Moutier co-led a successful suicide prevention and depression awareness program for health science faculty, residents, and students, which featured AFSP’s groundbreaking Interactive Screening Program. Since earning her medical degree and training in psychiatry at the University of California, San Diego, Moutier has been a practicing psychiatrist, professor and dean in the UCSD School of Medicine, medical director of the Inpatient Psychiatric Unit at the VA Medical Center in La Jolla, and has been clinically active with diverse patient populations, such as veterans, Asian refugee populations, as well as physicians and leaders with mental health conditions. She also served as co-investigator for the Sequenced Treatment Alternatives to Relieve Depression study (STAR*D), a large National Institute of Mental Health trial on the treatment of refractory depression. Moutier has authored articles and book chapters for publications such as the Journal of the American Medical Association, Academic Medicine, the American Journal of Psychiatry, the Journal of Clinical Psychiatry, Psychiatric Times, Depression and Anxiety, Academic Psychiatry, and most recently co-authored Stahl’s Clinical Handbook: Suicide Prevention Edition.John Awad, MD (OPDC)
Senior Medical Science Liaison
Speakers Guarava Agrawal, MD and Christine Moutier, MD are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc.
Speaker John Awad is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.Related Events
-
Monoamine Neurotransmitter Dysregulation in Major Depressive Disorder
December 17 12:00 pm to 1:00 pm -
Identification of Agitation in Patients with Dementia due to Alzheimer’s Disease: Perspectives from the Primary Care Provider
December 18 12:00 pm to 1:00 pm
Registration
Related Resources
-
Neuroprogression: Understanding How Mental Health Conditions Can Progress Over Time
Infographic November 14, 2024This infographic aims to educate patients and caregivers on the importance of early diagnosis and treatment of mental health conditions and to emphasize how delays in diagnosis and treatment can…
-
Introduction to PTSD
Infographic November 11, 2024This infographic aims to raise awareness of PTSD in a straightforward manner appropriate for both individuals with lived experience, and health care providers.
-
Factors in Designing & Evaluating Clinical Trials for App-Based Interventions
On-Demand Webinar November 4, 2024In this webinar, Dr. Sara Morimoto, PsyD will share her expertise in developing and testing app-based mental health interventions.
Join today for instant access to all PsychU content, events, and more!
Membership is free!
"*" indicates required fields
Join PsychU Today to receive a wide array of tools and benefits
- Join our multidisciplinary community that is improving mental health care… together
- Quickly learn more about the topics you're interested in
- Access an award-winning library of on-demand mental health resources
- Gain key insights from industry expert & thought leaders
Stay Connected: